COLL

Collegium Pharmaceutical Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth↓ 0/10
  • Momentum↑ 7/10
Collegium Pharmaceutical sales and earnings growth
COLL Growth
Low
  • Revenue Y/Y↑ 26.34%
  • EPS Y/Y↓ -31.73%
  • FCF Y/Y↑ 50.34%
Collegium Pharmaceutical gross and profit margin trends
COLL Profitability
Great
  • Gross margin ↑ 57.20%
  • EPS margin↓ 7.70%
  • ROIC↑ 18.70%
Collegium Pharmaceutical net debt vs free cash flow
COLL Risk
Fair
  • Debt / Equity↑ 3.0
  • Debt / FCF↓ 2.2
  • Interest coverage↓ 1.9

Collegium Pharmaceutical stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗